Back to Test Catalogue

Clozapine and Norclozapine, Plasma

Test ID: CLOZA

Test

Aliases/Synonyms

Clozaril

Method

LC-MSD

Report Includes

Clozapine; Norclozapine

Specimens

Avoid gel separator tubes; Plasma (EDTA); Plasma (Li Heparin); Serum

Clinical Utility

Toxic effects are centrally mediated (CNS) and concentration dependent.
Hematological effects, agranulocytosis, are concentration independent.

Test Location

London Health Sciences Centre, 339 Windermere Road, London ON N6A 5A5

Test Version

15-Jan-2024

Specimen

Specimens

Avoid gel separator tubes; Plasma (EDTA); Plasma (Li Heparin); Serum

Collection Containers

Preferred

Plasma (EDTA lavender top)

Acceptable

Plasma (green top Li Heparin); Serum (red top)

Sample Volume

1 mL

Minimum Volume

0.5 mL

Specimen Comment

Avoid gel separator tubes.

Collection & Handling

Handling Information

Store and send frozen.

Test Version

15-Jan-2024

Performance / Interpretation

Method

LC-MSD

Turnaround Time

7 days

Results

Name Units Reference Range Conversion Factor
Clozapine nmol/L
  • Minimum effective concentration: 1070
  • Laboratory Alert: > 3100
µg/L x 3.06
Norclozapine nmol/L
  • Therapeutic ranges not available.
µg/L x 3.19

Test Location

London Health Sciences Centre, 339 Windermere Road, London ON N6A 5A5

Test Version

15-Jan-2024

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
CLOZA 20707Clozapine,S nmol/L
20708Norclozapine,S nmol/L

Test Version

15-Jan-2024